Brown Advisory
BPMC

Brown Advisory’s Blueprint Medicines BPMC Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$58.8M Sell
458,559
-123,305
-21% -$15.8M 0.08% 176
2025
Q1
$51.5M Buy
581,864
+3,084
+0.5% +$273K 0.07% 182
2024
Q4
$50.5M Sell
578,780
-14,988
-3% -$1.31M 0.06% 207
2024
Q3
$54.9M Sell
593,768
-24,224
-4% -$2.24M 0.07% 209
2024
Q2
$66.6M Sell
617,992
-56,370
-8% -$6.08M 0.09% 168
2024
Q1
$64M Sell
674,362
-5,558
-0.8% -$527K 0.09% 169
2023
Q4
$62.7M Buy
679,920
+38,881
+6% +$3.59M 0.09% 170
2023
Q3
$32.2M Buy
641,039
+5,843
+0.9% +$293K 0.05% 253
2023
Q2
$40.1M Buy
635,196
+1,788
+0.3% +$113K 0.06% 225
2023
Q1
$28.5M Buy
633,408
+32,126
+5% +$1.45M 0.05% 272
2022
Q4
$26.3M Sell
601,282
-370,712
-38% -$16.2M 0.05% 278
2022
Q3
$64M Sell
971,994
-23,275
-2% -$1.53M 0.12% 149
2022
Q2
$50.3M Buy
995,269
+49,014
+5% +$2.48M 0.09% 173
2022
Q1
$60.4M Buy
946,255
+70,000
+8% +$4.47M 0.09% 178
2021
Q4
$93.9M Buy
876,255
+27,080
+3% +$2.9M 0.12% 125
2021
Q3
$87.3M Buy
849,175
+53,317
+7% +$5.48M 0.13% 133
2021
Q2
$70M Buy
795,858
+39,049
+5% +$3.43M 0.11% 160
2021
Q1
$73.6M Buy
756,809
+20,176
+3% +$1.96M 0.13% 140
2020
Q4
$82.6M Buy
736,633
+14,374
+2% +$1.61M 0.15% 119
2020
Q3
$67M Buy
722,259
+10,783
+2% +$1,000K 0.14% 115
2020
Q2
$55.5M Buy
711,476
+279,501
+65% +$21.8M 0.13% 127
2020
Q1
$25.3M Buy
431,975
+54,602
+14% +$3.19M 0.08% 182
2019
Q4
$30.2M Buy
377,373
+17,981
+5% +$1.44M 0.08% 198
2019
Q3
$26.4M Buy
359,392
+85,048
+31% +$6.25M 0.07% 202
2019
Q2
$25.9M Buy
274,344
+36,972
+16% +$3.49M 0.07% 218
2019
Q1
$19M Buy
+237,372
New +$19M 0.05% 254